Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franz Hartmann

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Journal of the American College of Cardiology|October 24, 2007
One-year results of the SCORPIUS study: a German multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patientsDietrich Baumgart, Volker Klauss, Frank Baer, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 30, 2013
Impact of infarct-related artery patency before primary PCI on outcome in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trialTomasz Rakowski, Dariusz Dudek, Artur Dziewierz, et al.
JACC. Cardiovascular Interventions|August 21, 2010
Impact of bivalirudin therapy in high-risk patients with acute myocardial infarction: 1-year results from the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) trialGuido Parodi, David Antoniucci, Eugenia Nikolsky, et al.
American Heart Journal|March 20, 2012
Five-year results of the Multicenter Randomized Controlled Open-Label Study of the CYPHER Sirolimus-Eluting Stent in the Treatment of Diabetic Patients with De Novo Native Coronary Artery Lesions (SCORPIUS) study: a German multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patientsJan-Malte Sinning, Dietrich Baumgart, Nikos Werner, et al.
European Journal of Heart Failure|February 28, 2004
NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP substudyFranz Hartmann, Milton Packer, Andrew J S Coats, et al.
Circulation|September 24, 2004
Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trialFranz Hartmann, Milton Packer, Andrew J S Coats, et al.
Circulation. Cardiovascular Interventions|March 3, 2011
Paclitaxel-eluting stents compared with bare metal stents in diabetic patients with acute myocardial infarction: the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trialBernhard Witzenbichler, Jochen Wöhrle, Giulio Guagliumi, et al.
Lancet (London, England)|June 14, 2011
Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trialGregg W Stone, Bernhard Witzenbichler, Giulio Guagliumi, et al.
The New England Journal of Medicine|May 24, 2008
Bivalirudin during primary PCI in acute myocardial infarctionGregg W Stone, Bernhard Witzenbichler, Giulio Guagliumi, et al.
Lancet (London, England)|September 1, 2009
Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trialRoxana Mehran, Alexandra J Lansky, Bernhard Witzenbichler, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Journal of the American College of Cardiology|October 24, 2007
One-year results of the SCORPIUS study: a German multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patientsDietrich Baumgart, Volker Klauss, Frank Baer, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 30, 2013
Impact of infarct-related artery patency before primary PCI on outcome in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trialTomasz Rakowski, Dariusz Dudek, Artur Dziewierz, et al.
JACC. Cardiovascular Interventions|August 21, 2010
Impact of bivalirudin therapy in high-risk patients with acute myocardial infarction: 1-year results from the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) trialGuido Parodi, David Antoniucci, Eugenia Nikolsky, et al.
American Heart Journal|March 20, 2012
Five-year results of the Multicenter Randomized Controlled Open-Label Study of the CYPHER Sirolimus-Eluting Stent in the Treatment of Diabetic Patients with De Novo Native Coronary Artery Lesions (SCORPIUS) study: a German multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patientsJan-Malte Sinning, Dietrich Baumgart, Nikos Werner, et al.
European Journal of Heart Failure|February 28, 2004
NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP substudyFranz Hartmann, Milton Packer, Andrew J S Coats, et al.
Circulation|September 24, 2004
Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trialFranz Hartmann, Milton Packer, Andrew J S Coats, et al.
Circulation. Cardiovascular Interventions|March 3, 2011
Paclitaxel-eluting stents compared with bare metal stents in diabetic patients with acute myocardial infarction: the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trialBernhard Witzenbichler, Jochen Wöhrle, Giulio Guagliumi, et al.
Lancet (London, England)|June 14, 2011
Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trialGregg W Stone, Bernhard Witzenbichler, Giulio Guagliumi, et al.
The New England Journal of Medicine|May 24, 2008
Bivalirudin during primary PCI in acute myocardial infarctionGregg W Stone, Bernhard Witzenbichler, Giulio Guagliumi, et al.
Lancet (London, England)|September 1, 2009
Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trialRoxana Mehran, Alexandra J Lansky, Bernhard Witzenbichler, et al.
Pageof 5